tiprankstipranks
Verrica Pharmaceuticals Strives for Nasdaq Compliance
Company Announcements

Verrica Pharmaceuticals Strives for Nasdaq Compliance

Don't Miss our Black Friday Offers:

The latest announcement is out from Verrica Pharmaceuticals ( (VRCA) ).

Verrica Pharmaceuticals Inc. finds itself temporarily non-compliant with Nasdaq’s independent director requirement following the immediate resignation of board member Craig Ballaron. The company has appointed Diem Nguyen to the Audit Committee, signaling steps toward rectifying the issue. Nasdaq has granted a cure period for compliance, which extends until the company’s next annual stockholders meeting or October 2, 2025, whichever comes first. If the meeting occurs before March 31, 2025, the company must comply by that date. Verrica Pharmaceuticals is confident it will meet the requirements within the provided timeframe.

See more data about VRCA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyVerrica Pharmaceuticals 44.96M share Spot Secondary priced at $0.89
TheFlyVerrica Pharmaceuticals prices 44.96M shares at 89c in public offering
TheFlyVerrica Pharmaceuticals announces common stock offering, no amount given
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App